pyridinoline has been researched along with Osteolysis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandrakis, MG; Katachanakis, C; Kyriakou, DS; Malliaraki, N; Margioris, AN; Passam, FH | 1 |
| Body, JJ; Delmas, PD; Dumon, JC; Gineyts, E | 1 |
| Garber, J; Greenspan, SL; Lee, SL; Moses, AC; Rosen, HN; Ross, DS | 1 |
1 trial(s) available for pyridinoline and Osteolysis
| Article | Year |
|---|---|
Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates.
Topics: Alkaline Phosphatase; Amino Acids; Antineoplastic Agents; Biomarkers; Bone and Bones; Bone Resorption; Carcinoma, Papillary; Collagen; Collagen Type I; Creatinine; Diphosphonates; Double-Blind Method; Fasting; Humans; Osteocalcin; Osteolysis; Pamidronate; Peptides; Thyroid Neoplasms; Thyroxine | 1998 |
2 other study(ies) available for pyridinoline and Osteolysis
| Article | Year |
|---|---|
Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients.
Topics: Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Remodeling; Case-Control Studies; Collagen; Collagen Type I; Disease Progression; Female; Humans; Male; Multiple Myeloma; Neoplasm Staging; Osteocalcin; Osteolysis; Peptides; Severity of Illness Index | 2002 |
Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy.
Topics: Adult; Aged; Amino Acids; Analysis of Variance; Biomarkers; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Diphosphonates; Female; Humans; Hydroxyproline; Middle Aged; Osteolysis; Pamidronate; Postmenopause; Regression Analysis | 1997 |